loadpatents
Patent applications and USPTO patent grants for HIRATA; Jamie Harue.The latest application filed is for "methods of using anti-cd79b immunoconjugates to treat follicular lymphoma".
Patent | Date |
---|---|
METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES TO TREAT FOLLICULAR LYMPHOMA App 20220125942 - MUSICK; Lisa ;   et al. | 2022-04-28 |
METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES App 20220040153 - POLSON; Andrew ;   et al. | 2022-02-10 |
Combination Therapy Of Diffuse Large B-cell Lymphoma Comprising An Anti-cd79b Immunoconjugates, An Alkylating Agent And An Anti-cd20 Antibody App 20220031861 - HIRATA; Jamie Harue ;   et al. | 2022-02-03 |
METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES App 20210346352 - POLSON; Andrew ;   et al. | 2021-11-11 |
Methods of using anti-CD79b immunoconjugates Grant 11,000,510 - Polson , et al. May 11, 2 | 2021-05-11 |
Methods Of Using Anti-cd79b Immunoconjugates To Treat Diffuse Large B-cell Lymphoma App 20210115141 - HERNANDEZ MONTALVO; Juana Elva ;   et al. | 2021-04-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.